RecruitingNot applicableNCT05734521
Avalglucosidase Alfa Pregnancy Study
Studying Pompe disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Sanofi
- Principal Investigator
- Clinical Sciences & OperationsSanofi
- Intervention
- avalglucosidase alfa-NGPT (GZ402666) IV(biological)
- Enrollment
- 100 enrolled
- Eligibility
- FEMALE
- Timeline
- 2022 – 2032
Study locations (1)
- Investigational site worldwide, Bridgewater, New Jersey, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05734521 on ClinicalTrials.gov